Series A funding led by Bain Capital Ventures; positions health-tech company for expansion
MINNEAPOLIS – April 13, 2017 – Sansoro Health, an award-winning pioneer in data integration for health care, today announced that it has closed $5.2 million in Series A funding led by Bain Capital Ventures. Sansoro Health makes it easy to exchange real-time health care data between digital health applications and electronic medical records (EMRs). The new funding will be used to expand sales, marketing and operations to accelerate Sansoro Health’s vision of transforming health care IT ecosystems through real-time digital health interoperability.
“Innovation in health care will drive improved patient outcomes at lower cost, and meaningful change demands modern, secure data exchange,” explains Jeremy Edes Pierotti, CEO, Sansoro Health. “True interoperability empowers health care organizations to evolve, adapt and innovate to serve patients. We could not be happier to have the recognition and partnership of Bain Capital Ventures, a leading health care and technology investor that recognizes what is needed in health care to accelerate progress.”
Sansoro Health won the 10th annual Venture+ Forum startup competition as part of the 2016 Healthcare Information and Management Systems Society (HIMSS) Annual Conference. The company was also selected by Healthcare Informatics as one of only six national “Up and Comers 2016.” Additionally, Sansoro Health won the Software and Web Applications category of the 2016 annual Leaders in Health Care Awards, presented by Minnesota Business.
Sansoro Health’s integration software Emissary™ creates value for leaders across digital health, insurance, life sciences and health systems by quickly and securely connecting applications to EMRs for a seamless exchange of health data. The plug-and-play solution leverages robust web services to provide bi-directional, EMR-agnostic APIs to connect third-party technology products with major EMR platforms. Emissary has been implemented by nearly 20 healthcare organizations since its introduction in 2015 – facilitating the exchange of thousands of API calls per month.
“Sansoro Health solves the #1 problem for most hospital CIOs, who often have a 2-3 year backlog of systems to integrate,” said Yumin Choi, managing director of Bain Capital Ventures. “Jeremy has built a spectacular team with deep industry expertise, and they’ve developed an elegant solution that is far superior to anything we’ve seen in this space. Unlike other vendors that rely on limiting data formats, Sansoro offers robust integration that can cut implementation from months to days.”
BCV has a long history of success in healthcare technology and services. Active portfolio companies include Apixio (healthcare data science), Quanterix (high-definition diagnostics) and Remedy Partners (bundled payment SaaS and services). Prior exits include ABILITY Network (Summit Partners); Accelecare (Healogics); Boston Heart Diagnostics (Eurofins); Enclarity (LexisNexis); Humedica (UnitedHealth); Liazon (Towers Watson); Liberty Dialysis (Fresenius); MedeAnalytics (Thoma Bravo); MedHOK (Hearst); MinuteClinic (CVS); and National Cardiovascular Partners (Fresenius).
Prior to the Series A investment, Sansoro Health received $1.2 million in seed funding in 2016, led by San Francisco-based investor Healthy Ventures with additional funds from TreeHouse Health and angel investors.
About Sansoro Health
Sansoro Health makes it easy to exchange real-time health care data between digital health applications and electronic medical records. Sansoro’s core product, EmissaryTM, leverages APIs for a quick and secure plug and-play solution enabling innovators to scale quickly and health care to take the next big step towards true interoperability. For more information, visit https://sansorohealth.com.
About Bain Capital Ventures
Bain Capital Ventures partners with disruptive B2B founders to accelerate their ideas to market. The firm invests from seed to growth in enterprise software, infrastructure software and industries being transformed by data. BCV has helped launch and commercialize 200-plus companies since 1984, including investments in DocuSign, Kiva Systems, LinkedIn, Rapid7, SurveyMonkey, Taleo and TellApart. BCV has approximately $3.7 billion of assets under management with offices in San Francisco, New York and Boston. Follow BCV via LinkedIn or Twitter.